Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmacology and Experimental Therapeutics is Scopus-indexed (Q2, CiteScore 5.2), WoS SCIE. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0022-3565Verify ISSN ↗1521-0103Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,750 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 130 / 328 | 60th | Q2 |
| Molecular Medicine | 97 / 179 | 46th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1945–present, best quartile Q2, CiteScore 5.2.
Journal of Pharmacology and Experimental Therapeutics is Q2 in Pharmacology (rank 130 of 328) and Q3 in Molecular Medicine (rank 97 of 179), by CiteScore 2025.
Journal of Pharmacology and Experimental Therapeutics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.2, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.921, quartile Q2, with an H-index of 254.
The publisher lists an article processing charge of about US$3,750 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Pharmacology and Experimental Therapeutics is published by Elsevier Inc. Its print ISSN is 0022-3565 and its online ISSN is 1521-0103.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Pharmacology and Experimental Therapeutics has an h-index of 326 and a 2-year mean of 0.96 citations per paper (OpenAlex). Its Scopus CiteScore is 5.2, quartile Q2. On 2-year citations it ranks #237 of 319 Scopus journals in Pharmacology.
Journal of Pharmacology and Experimental Therapeutics published 821 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2026), authors are most often from United States (33.1%), China (20.5%) and India (5.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 33 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.